Current Liabilities
Bristol-Myers Squibb·Balance Sheet Statement·7 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total current liabilities | $23.3B | $22.6B | $23.8B | $24.1B | $27.5B | $28.1B | $23.4B | $19.2B |
| Other accrued liabilities | $16B | $18.1B | $18.1B | $16.5B | $17.4B | $19.3B | $17.6B | $12.6B |
| Accounts payable | $3.8B | $3.5B | $3.6B | $4B | $5.4B | $4.3B | $3.6B | $4.2B |
| Current portion of long-term debt | $3.5B | $1.1B | $2B | $3.6B | $4.7B | $4.5B | $2.3B | $2.3B |
| Short-term borrowings | $3.5B | $1.1B | $2B | $3.6B | $4.7B | $4.5B | $2.3B | $2.3B |
| Operating lease liabilities, current | $177M | $165M | $181M | $172M | $194M | $214M | $202M | $199M |
| Income taxes payable | -$1.9B | -$348M | $0 | $54M | -$621M | $887M | -$324M | $187M |